Functional polymorphisms of folate metabolism and response to chemotherapy for colorectal cancer, a systematic review and meta-analysis.
作者： Barbara Anne Jennings , Chun Shing Kwok , Gavin Willis , Victoria Matthews , Pawel Wawruch
DOI: 10.1097/FPC.0B013E328351875D
关键词:
摘要: … observational studies of colorectal cancer patients treated with chemotherapy and that also … The chemotherapy agents used in eligible studies included capecitabine, tegafur or 5-FU (…
manchester.ac.uk
uea.ac.uk
lww.com参考文章(54)
Isabelle Morin, Nelly Sabbaghian, Gerald Batist, Rima Rozen, Valerie Panet-Raymond, Victor Cohen, Methylenetetrahydrofolate reductase polymorphism in advanced colorectal cancer: a novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy. Clinical Cancer Research. ,vol. 9, pp. 1611- 1615 ,(2003)
Go Watanabe, Kazuyuki Kawakami, Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene. Cancer Research. ,vol. 63, pp. 6004- 6007 ,(2003)
William G Johnson, Theresa O Scholl, John R Spychala, Steven Buyske, Edward S Stenroos, Xinhua Chen, Common dihydrofolate reductase 19–base pair deletion allele: a novel risk factor for preterm delivery The American Journal of Clinical Nutrition. ,vol. 81, pp. 664- 668 ,(2005) , 10.1093/AJCN/81.3.664
F Graziano, A Ruzzo, F Loupakis, D Santini, V Catalano, E Canestrari, P Maltese, R Bisonni, L Fornaro, G Baldi, G Masi, A Falcone, G Tonini, P Giordani, P Alessandroni, L Giustini, B Vincenzi, M Magnani, Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy. British Journal of Cancer. ,vol. 99, pp. 716- 721 ,(2008) , 10.1038/SJ.BJC.6604555
Josefa Salgado, Natalia Zabalegui, Carmen Gil, Ignacio Monreal, Javier Rodríguez, Jesús García-Foncillas, Polymorphisms in the thymidylate synthase and dihydropyrimidine dehydrogenase genes predict response and toxicity to capecitabine-raltitrexed in colorectal cancer. Oncology Reports. ,vol. 17, pp. 325- 328 ,(2007) , 10.3892/OR.17.2.325
Ilan Weisberg, Pamela Tran, Benedicte Christensen, Sahar Sibani, Rima Rozen, A Second Genetic Polymorphism in Methylenetetrahydrofolate Reductase (MTHFR) Associated with Decreased Enzyme Activity Molecular Genetics and Metabolism. ,vol. 64, pp. 169- 172 ,(1998) , 10.1006/MGME.1998.2714
Marleen J. Gosens, Elna Moerland, Valery P. Lemmens, Harm T. Rutten, Ivonne Tan-Go, Adriaan J. van den Brule, Thymidylate synthase genotyping is more predictive for therapy response than immunohistochemistry in patients with colon cancer. International Journal of Cancer. ,vol. 123, pp. 1941- 1949 ,(2008) , 10.1002/IJC.23740
C E de Bock, M B Garg, N Scott, J A Sakoff, F E Scorgie, S P Ackland, L F Lincz, Association of thymidylate synthase enhancer region polymorphisms with thymidylate synthase activity in vivo Pharmacogenomics Journal. ,vol. 11, pp. 307- 314 ,(2011) , 10.1038/TPJ.2010.43
David J. Park, Jan Stoehlmacher, Wu Zhang, Denice Tsao-Wei, Susan Groshen, Heinz-Josef Lenz, Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer International Journal of Colorectal Disease. ,vol. 17, pp. 46- 49 ,(2002) , 10.1007/S003840100358
Salvatore Terrazzino, Marco Agostini, Salvatore Pucciarelli, Lara Maria Pasetto, Maria Luisa Friso, Alessandro Ambrosi, Veronica Lisi, Alberta Leon, Mario Lise, Donato Nitti, A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation Pharmacogenetics and Genomics. ,vol. 16, pp. 817- 824 ,(2006) , 10.1097/01.FPC.0000230412.89973.C0